New research from the Yale School of Medicine indicates that extreme heat and fine particle air pollution pose a greater threat to cardiovascular health than previously understood. Studies show these environmental stressors can trigger subtle, cumulative damage to heart function, even in older adults without prior history of heart disease, and correlate with a 12-17% … Read more
Medicare prescriptions for the anti-obesity medication Wegovy surged 598% in the six months following a federal policy shift that allowed coverage for heart disease prevention. Despite this increase, new research from the USC Schaeffer Center for Health Policy & Economics reveals that less than 1% of the estimated 3.6 million eligible beneficiaries have accessed the … Read more
Adults with coronary heart disease (CHD) who follow diets supporting gut microbiota health may face a lower risk of all-cause mortality, according to a retrospective cohort analysis published in the journal Medicine. Researchers using NHANES data (2005–2018) found that participants with the highest Dietary Index for Gut Microbiota (DI-GM) scores had significantly lower death rates … Read more
Italy is experiencing a profound demographic shift toward extreme longevity, with the highest concentrations of centenarians and oldest-old populations appearing in the North and Center, according to a study published in the journal Nutrients. Researchers found that while regions like Liguria lead in aging profiles, southern hotspots such as Cilento maintain survival rates comparable to … Read more
The updated ABCs of cardiovascular disease (CVD) prevention framework, published in the American Journal of Preventive Cardiology in 2026, provides a standardized, evidence-based roadmap for clinicians to manage heart health across a patient’s lifespan. By integrating tools like the PREVENT™ risk scoring system and addressing Cardiovascular-Kidney-Metabolic (CKM) syndrome, the framework shifts clinical focus toward early, … Read more
Researchers at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have identified a new molecular mechanism driving hypertrophic cardiomyopathy, the most common inherited heart disease. A study published in Nature Cardiovascular Research confirms that the targeted therapy mavacamten remains effective across various genetic mutations, potentially expanding treatment options for the estimated 95,230 patients living with the … Read more
Federal prosecutors have charged Texas physician Jason Finkelstein with healthcare fraud and conspiracy, alleging he orchestrated an $89 million scheme that billed insurers for unnecessary cardiovascular screenings of college athletes. According to the U.S. Department of Justice, Finkelstein routinely certified test results as “normal” without reviewing them, leading to undetected cardiac issues in patients and … Read more
Researchers at the Boston University School of Public Health (BUSPH) and Boston Medical Center (BMC) are launching a $3.2 million study to determine if monitoring postpartum blood pressure can prevent recurrent hypertensive disorders of pregnancy (HDP). Led by Dr. Samantha Parker Kelleher and Dr. Christina Yarrington, the five-year project aims to identify early interventions for … Read more
Low blood pressure, or hypotension, is linked to a significantly higher risk of developing Alzheimer’s disease, according to a study published in the Journal of the American Heart Association. Researchers analyzing data from nearly 800,000 adults found that individuals with low blood pressure were up to three times more likely to be diagnosed with Alzheimer’s … Read more
New research published in Nature Medicine reveals that the medication dapagliflozin significantly reduces the risk of heart failure in patients who carry specific cardiomyopathy-associated genetic variants. Findings from the Mass General Brigham Heart and Vascular Institute and the Broad Institute of MIT and Harvard suggest that these genetic markers could help clinicians identify patients who … Read more